Results 231 to 240 of about 2,742,900 (350)
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Editorial: 10 years of Frontiers in cell and developmental biology: past discoveries, current challenges and future perspectives. [PDF]
Fisher AG.
europepmc +1 more source
The revolutionary developmental biology of Wilhelm His, Sr. [PDF]
Richardson MK, Keuck G.
europepmc +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
On the evolutionary developmental biology of the cell. [PDF]
Babonis LS.
europepmc +1 more source
Reflections on the past, present and future of developmental biology. [PDF]
Stern CD.
europepmc +1 more source
Computer modeling in developmental biology: growing today, essential tomorrow
J. Sharpe
semanticscholar +1 more source
Charles Darwin and the Origins of Plant Evolutionary Developmental Biology [PDF]
William E. Friedman, Pamela K. Diggle
openalex +1 more source
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source

